Mechlorethamine in psoriasis. Further attempts to induce immunological tolerance.
Further attempts to induce immunological tolerance in 29 psoriatic patients treated topically with mechlorethamine hydrochloride have not been successful using the intravenous route. The rate of sensitization achieved (65%) is not substantially different from the rate for those patients who had no attempt to induce tolerance (55.5%).
D000328:Adult; D003877:Dermatitis, Contact / Q000276:immunology*; D006801:Humans; D006967:Hypersensitivity / Q000517:prevention & control; D007108:Immune Tolerance; D008297:Male; D008466:Mechlorethamine / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use*; D011565:Psoriasis / Q000188:drug therapy*
D008466:Mechlorethamine